site stats

Immunic investor relations

Witryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining …

4SC sells immunology portfolio to Immunic - 4SC AG

Witryna5 kwi 2024 · Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune … Investor Relations. IR Home; News Releases; Events and Presentations; Stock … Webcasts and presentations that have been archived are available by viewing hi… 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 3… Immunic Therapeutics Jessica Breu Head of Investor Relations and Communic… Immunic is privately held and supported by several renowned healthcare invest… Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group … porthcawl seafront cafe https://sullivanbabin.com

Immunic, Inc. to Participate in Upcoming Investor and Industry

Witryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... Witryna13 kwi 2024 · Overview. Rocket Companies (NYSE: RKT) is a Detroit-based holding company consisting of personal finance and consumer service brands. Founded by Dan Gilbert, tech-driven Rocket Companies provides industry-leading real estate, mortgage and financial services, empowering consumers through entities including Rocket … Witryna23 sie 2024 · Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. ... Head of Investor Relations and Communications. Standort. Größere Karte. Gräfelfing. Lochhamer Schlag 21, 82166 … porthcawl seaside news

Immunic, Inc. Reports Year End 2024 Financial Results and ... - BioSpace

Category:Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript

Tags:Immunic investor relations

Immunic investor relations

Immunic to Participate in Investor and Scientific Conferences in ...

Witryna23 lut 2024 · /PRNewswire/ -- Immunic, Inc. (NASDAQ: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … Witryna15 lip 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications …

Immunic investor relations

Did you know?

Witryna12 kwi 2024 · Immunic, Inc. Jessica Breu Manager IR and Communications +49 89 250 0794 69 [email protected] Or Rx Communications Group Melody Carey +1-917-322-2571 [email protected] Witryna24 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula Schwartz

Witryna1 wrz 2024 · Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, and Jessica Breu, Head of Investor Relations and Communications at Immunic, will … Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications …

Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected]. US Media ... Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and …

WitrynaInvestor updates. Past IR events View all events. Investors. 2024 Credit Suisse Global Healthcare Conference. Read more. Investors. ... Investor relations team contacts. Genentech. Genentech has been delivering on the promise of biotechnology for over 35 years. Discover more. Contact. Locations.

WitrynaM.A. Business Management Student, Investor Relations and PR at Immunic Therapeutics Metropolregion München. 95 Follower:innen … optex technical supportWitryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … optex systems richardsonWitryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE … optex systems.comWitryna3 kwi 2024 · Investor Home. Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead … porthcawl secondary schoolWitryna22 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected] optex systems richardson txWitryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of … optex treuhand agWitryna5 kwi 2024 · Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and … porthcawl sewage